82_FR_46687 82 FR 46495 - Mine Safety and Health Research Advisory Committee (MSHRAC) [email protected] or by phone at least 5 business days in advance of the meeting."> [email protected] or by phone at least 5 business days in advance of the meeting." /> [email protected] or by phone at least 5 business days in advance of the meeting." />

82 FR 46495 - Mine Safety and Health Research Advisory Committee (MSHRAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 192 (October 5, 2017)

Page Range46495-46496
FR Document2017-21423

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), announces the following meeting for the Mine Safety and Health Research Advisory Committee (MSHRAC). This meeting is open to the public, limited only by the limited only by the space available. The meeting room accommodates approximately 50 people. If you wish to attend in person or by phone, please contact Marie Chovanec by email at [email protected] or by phone at least 5 business days in advance of the meeting.

Federal Register, Volume 82 Issue 192 (Thursday, October 5, 2017) 
[Federal Register Volume 82, Number 192 (Thursday, October 5, 2017)]
[Notices]
[Pages 46495-46496]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-21423]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Mine Safety and Health Research Advisory Committee (MSHRAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), National Institute 
for Occupational Safety and Health (NIOSH), announces the following 
meeting for the Mine Safety and Health Research Advisory Committee 
(MSHRAC). This meeting is open to the public, limited only by the 
limited only by the space available. The meeting room accommodates 
approximately 50 people. If you wish to attend in person or by phone, 
please contact Marie Chovanec by email at [email protected] or by phone 
at least 5 business days in advance of the meeting.

DATES: The meeting will be held on November 15, 2017, 8:00 a.m.-3:00 
p.m., Mountain Time.

ADDRESSES: Sheraton Denver West Hotel, 360 Union Boulevard, Lakewood, 
CO 80228 or call 412-386-5302.

FOR FURTHER INFORMATION CONTACT: Jeffrey H. Welsh, Designated Federal 
Officer, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 
15236, telephone 412-386-4040, fax 412-386-6614.

SUPPLEMENTARY INFORMATION: 
    Purpose: This committee is charged with providing advice to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
and the Director, NIOSH, on priorities in mine safety and health 
research, including grants and contracts for such research, 30 U.S.C. 
812(b)(2), Section 102(b)(2).
    Matters To Be Considered: The meeting will focus on mining safety 
and health research projects and outcomes, including built-in-place 
refuge alternatives, explosion protection, domestic and international

[[Page 46496]]

collaborations, fatigue management systems, mitigating dynamic failure 
in western underground coal mines, mining strategic planning, and 
mining innovations research initiative. Agenda items are subject to 
change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-21423 Filed 10-4-17; 8:45 am]
 BILLING CODE 4163-19-P

Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices 46495 Federal Communications Commission. and Administrator, NCEH/ATSDR, are Prevention and the Agency for Toxic Marlene H. Dortch, authorized under Section 301 (42 U.S.C. Substances and Disease Registry. Secretary, Office of the Secretary. 241) and Section 311 (42 U.S.C. 243) of Elaine L. Baker, [FR Doc. 2017–21482 Filed 10–4–17; 8:45 am] the Public Health Service Act, as Director, Management Analysis and Services BILLING CODE 6712–01–P amended, to: (1) Conduct, encourage, Office, Centers for Disease Control and cooperate with, and assist other Prevention. appropriate public authorities, scientific [FR Doc. 2017–21422 Filed 10–4–17; 8:45 am] DEPARTMENT OF HEALTH AND institutions, and scientists in the BILLING CODE 4163–19–P HUMAN SERVICES conduct of research, investigations, experiments, demonstrations, and Centers for Disease Control and studies relating to the causes, diagnosis, DEPARTMENT OF HEALTH AND Prevention treatment, control, and prevention of HUMAN SERVICES physical and mental diseases and other Board of Scientific Counselors, impairments; (2) assist states and their Centers for Disease Control and National Center for Environmental political subdivisions in the prevention Prevention Health/Agency for Toxic Substances of infectious diseases and other and Disease Registry (BSC, NCEH/ Mine Safety and Health Research preventable conditions and in the ATSDR) Advisory Committee (MSHRAC) promotion of health and wellbeing; and AGENCY: Centers for Disease Control and (3) train state and local personnel in AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health health work. The BSC, NCEH/ATSDR Prevention (CDC), Department of Health and Human Services (HHS). provides advice and guidance to the and Human Services (HHS). ACTION: Notice of meeting. Secretary, HHS; the Director, CDC and ACTION: Notice of meeting. Administrator, ATSDR; and the SUMMARY: In accordance with the Director, NCEH/ATSDR, regarding SUMMARY: In accordance with the Federal Advisory Committee Act, the program goals, objectives, strategies, and Federal Advisory Committee Act, the Centers for Disease Control and priorities in fulfillment of the agency’s Centers for Disease Control and Prevention (CDC), announces the mission to protect and promote people’s Prevention (CDC), National Institute for following meeting for the Board of health. The board provides advice and Occupational Safety and Health Scientific Counselors, National Center guidance that will assist NCEH/ATSDR (NIOSH), announces the following for Environmental Health/Agency for meeting for the Mine Safety and Health in ensuring scientific quality, Toxic Substances and Disease Registry Research Advisory Committee timeliness, utility, and dissemination of (BSC, NCEH/ATSDR). This meeting is (MSHRAC). This meeting is open to the results. The board also provides open to the public, limited in the room public, limited only by the limited only guidance to help NCEH/ATSDR work by 60 people and 75 lines over the by the space available. The meeting more efficiently and effectively with its phone. The public is also welcome to room accommodates approximately 50 listen to the meeting by 1–888–790– various constituents and to fulfill its people. If you wish to attend in person 2009, passcode: 7865774, with 75 lines. mission in protecting America’s health. or by phone, please contact Marie The deadline for notification of Matters To Be Considered: The agenda Chovanec by email at MChovanec@ attendance is November 10, 2017. The will include discussions on NCEH/ cdc.gov or by phone at least 5 business public comment period is scheduled on ATSDR Director Updates; Noise- days in advance of the meeting. Wednesday, November 15, 2017 from Induced Hearing Loss; NCEH/ATSDR DATES: The meeting will be held on 2:00 p.m. until 2:15 p.m.; and from 3:25 Program Responses to BSC Guidance November 15, 2017, 8:00 a.m.–3:00 p.m. until 3:40 p.m. EST, and on and Action Items; CDC’s Hurricane p.m., Mountain Time. Thursday, November 16, 2017 from Season Response; Lead Poisoning ADDRESSES: Sheraton Denver West 10:10 a.m. until 10:25 a.m. EST. Prevention Program Updates; Flint Hotel, 360 Union Boulevard, Lakewood, Individuals wishing to make a comment Registry; Revision of blood lead level CO 80228 or call 412–386–5302. during Public Comment period, please reference value (status); Discussion of email your name, organization, and FOR FURTHER INFORMATION CONTACT: Legislative Requirements of new Lead phone number by November 6, 2017 to Jeffrey H. Welsh, Designated Federal Exposure Poisoning Federal Advisory William Cibulas at wic1@cdc.gov. Officer, MSHRAC, NIOSH, CDC, 626 Committee; Amyotrophic Lateral Cochrans Mill Road, Pittsburgh, PA DATES: The meeting will be held on Sclerosis (ALS) Program Update; 15236, telephone 412–386–4040, fax November 15, 2017, 8:30 a.m. to 4:30 Environmental Health Tracking Program 412–386–6614. p.m., EST and November 16, 2017, 8:30 update; updates from the National a.m. to noon, EST. SUPPLEMENTARY INFORMATION: Institute of Environmental Health Sciences, the National Institute for Purpose: This committee is charged ADDRESSES: CDC, 4770 Buford Hwy., with providing advice to the Secretary, Atlanta, Georgia 30341, Building 107, Occupational Safety and Health, the Department of Health and Human Room 1A or by phone: 1–888–790–2009 U.S. Department of Energy and the U.S. Services; the Director, CDC; and the FOR FURTHER INFORMATION CONTACT: Environmental Protection Agency. Director, NIOSH, on priorities in mine Shirley Little, Program Analyst, NCEH/ Agenda items are subject to change as safety and health research, including ATSDR, CDC, 4770 Buford Hwy., Mail priorities dictate. grants and contracts for such research, ethrower on DSK3G9T082PROD with NOTICES Stop F–45, Atlanta, Georgia 30341, The Director, Management Analysis 30 U.S.C. 812(b)(2), Section 102(b)(2). telephone (770) 488–0577; snl7@ and Services Office, has been delegated Matters To Be Considered: The cdc.gov. the authority to sign Federal Register meeting will focus on mining safety and SUPPLEMENTARY INFORMATION: notices pertaining to announcements of health research projects and outcomes, Purpose: The Secretary, Department meetings and other committee including built-in-place refuge of Health and Human Services (HHS) management activities, for both the alternatives, explosion protection, and by delegation, the Director, CDC Centers for Disease Control and domestic and international VerDate Sep<11>2014 19:52 Oct 04, 2017 Jkt 244001 PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 E:\FR\FM\05OCN1.SGM 05OCN1

46496 Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices collaborations, fatigue management considered. Electronic comments must Submissions,’’ publicly viewable at systems, mitigating dynamic failure in be submitted on or before December 4, https://www.regulations.gov or at the western underground coal mines, 2017. The https://www.regulations.gov Dockets Management Staff between 9 mining strategic planning, and mining electronic filing system will accept a.m. and 4 p.m., Monday through innovations research initiative. Agenda comments until midnight Eastern Time Friday. items are subject to change as priorities at the end of December 4, 2017. • Confidential Submissions—To dictate. Comments received by mail/hand submit a comment with confidential The Director, Management Analysis delivery/courier (for written/paper information that you do not wish to be and Services Office, has been delegated submissions) will be considered timely made publicly available, submit your the authority to sign Federal Register if they are postmarked or the delivery comments only as a written/paper notices pertaining to announcements of service acceptance receipt is on or submission. You should submit two meetings and other committee before that date. copies total. One copy will include the management activities, for both the information you claim to be confidential Electronic Submissions Centers for Disease Control and with a heading or cover note that states Prevention and the Agency for Toxic Submit electronic comments in the ‘‘THIS DOCUMENT CONTAINS Substances and Disease Registry. following way: CONFIDENTIAL INFORMATION.’’ The • Federal eRulemaking Portal: Agency will review this copy, including Elaine L. Baker, https://www.regulations.gov. Follow the the claimed confidential information, in Director, Management Analysis and Services instructions for submitting comments. its consideration of comments. The Office, Centers for Disease Control and Comments submitted electronically, Prevention. second copy, which will have the including attachments, to https:// claimed confidential information [FR Doc. 2017–21423 Filed 10–4–17; 8:45 am] www.regulations.gov will be posted to redacted/blacked out, will be available BILLING CODE 4163–19–P the docket unchanged. Because your for public viewing and posted on comment will be made public, you are https://www.regulations.gov. Submit solely responsible for ensuring that your both copies to the Dockets Management DEPARTMENT OF HEALTH AND comment does not include any HUMAN SERVICES Staff. If you do not wish your name and confidential information that you or a contact information to be made publicly third party may not wish to be posted, available, you can provide this Food and Drug Administration such as medical information, your or information on the cover sheet and not [Docket No. FDA–2016–E–2479] anyone else’s Social Security number, or in the body of your comments and you confidential business information, such must identify this information as Determination of Regulatory Review as a manufacturing process. Please note ‘‘confidential.’’ Any information marked Period for Purposes of Patent that if you include your name, contact as ‘‘confidential’’ will not be disclosed Extension; KOVALTRY information, or other information that except in accordance with § 10.20 (21 AGENCY: Food and Drug Administration, identifies you in the body of your CFR 10.20) and other applicable HHS. comments, that information will be disclosure law. For more information ACTION: Notice. posted on https://www.regulations.gov. about FDA’s posting of comments to • If you want to submit a comment public dockets, see 80 FR 56469, SUMMARY: The Food and Drug with confidential information that you September 18, 2015, or access the Administration (FDA or the Agency) has do not wish to be made available to the information at: https://www.gpo.gov/ determined the regulatory review period public, submit the comment as a fdsys/pkg/FR-2015-09-18/pdf/2015- for KOVALTRY and is publishing this written/paper submission and in the 23389.pdf. notice of that determination as required manner detailed (see ‘‘Written/Paper Docket: For access to the docket to by law. FDA has made the Submissions’’ and ‘‘Instructions’’). read background documents or the determination because of the Written/Paper Submissions electronic and written/paper comments submission of an application to the received, go to https:// Director of the U.S. Patent and Submit written/paper submissions as www.regulations.gov and insert the Trademark Office (USPTO), Department follows: • Mail/Hand delivery/Courier (for docket number, found in brackets in the of Commerce, for the extension of a heading of this document, into the written/paper submissions): Dockets patent which claims that human ‘‘Search’’ box and follow the prompts Management Staff (HFA–305), Food and biological product. and/or go to the Dockets Management Drug Administration, 5630 Fishers DATES: Anyone with knowledge that any Lane, Rm. 1061, Rockville, MD 20852. Staff, 5630 Fishers Lane, Rm. 1061, of the dates as published (in the • For written/paper comments Rockville, MD 20852. SUPPLEMENTARY INFORMATION section) are submitted to the Dockets Management FOR FURTHER INFORMATION CONTACT: incorrect may submit either electronic Staff, FDA will post your comment, as Beverly Friedman, Office of Regulatory or written comments and ask for a well as any attachments, except for Policy, Food and Drug Administration, redetermination by December 4, 2017. information submitted, marked and 10903 New Hampshire Ave., Bldg. 51, Furthermore, any interested person may identified, as confidential, if submitted Rm. 6250, Silver Spring, MD 20993, petition FDA for a determination as detailed in ‘‘Instructions.’’ 301–796–3600. regarding whether the applicant for Instructions: All submissions received SUPPLEMENTARY INFORMATION: extension acted with due diligence must include the Docket No. FDA– ethrower on DSK3G9T082PROD with NOTICES during the regulatory review period by 2016–E–2479 for ’’Determination of I. Background April 3, 2018. See ‘‘Petitions’’ in the Regulatory Review Period for Purposes The Drug Price Competition and SUPPLEMENTARY INFORMATION section for of Patent Extension; KOVALTRY.’’ Patent Term Restoration Act of 1984 more information. Received comments, those filed in a (Pub. L. 98–417) and the Generic ADDRESSES: You may submit comments timely manner (see ADDRESSES), will be Animal Drug and Patent Term as follows. Please note that late, placed in the docket and, except for Restoration Act (Pub. L. 100–670) untimely filed comments will not be those submitted as ‘‘Confidential generally provide that a patent may be VerDate Sep<11>2014 19:52 Oct 04, 2017 Jkt 244001 PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\05OCN1.SGM 05OCN1


Document Created: 2017-10-05 00:53:54
Document Modified: 2017-10-05 00:53:54
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe meeting will be held on November 15, 2017, 8:00 a.m.-3:00 p.m., Mountain Time.
ContactJeffrey H. Welsh, Designated Federal Officer, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 15236, telephone 412-386-4040, fax 412-386-6614.
FR Citation82 FR 46495 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR